Notice: Undefined index: action in /home/impactinvesting/public_html/wp-content/themes/voice-child/functions.php on line 2
JPMorgan Chase Adjusts Price Target on The Beauty Health to $12 From $13, Maintains Neutral Rating | MarketScreener – Impact investing
3. GOOD HEALTH AND WELL-BEING

JPMorgan Chase Adjusts Price Target on The Beauty Health to $12 From $13, Maintains Neutral Rating | MarketScreener

Written by Amanda

05/26/2023 | 10:22am EDT

© MT Newswires 2023

All news about THE BEAUTY HEALTH COMPANY

Analyst Recommendations on THE BEAUTY HEALTH COMPANY

Financials (USD)

Sales 2023 465 M
Net income 2023 14,5 M
Net Debt 2023 173 M
P/E ratio 2023 105x
Yield 2023
Capitalization 1 283 M 1 283 M
EV / Sales 2023 3,13x
EV / Sales 2024 2,53x
Nbr of Employees 1 034
Free-Float 98,8%

Chart THE BEAUTY HEALTH COMPANY

Duration :


Period :

The Beauty Health Company Technical Analysis Chart | MarketScreener

Technical analysis trends THE BEAUTY HEALTH COMPANY

Short Term Mid-Term Long Term
Trends Bearish Neutral Neutral

Income Statement Evolution

Please enable JavaScript in your browser’s settings to use dynamic charts.

Sell

Buy

Mean consensus BUY
Number of Analysts 11
Last Close Price 9,67 $
Average target price 18,11 $
Spread / Average Target 87,3%

EPS Revisions

Please enable JavaScript in your browser’s settings to use dynamic charts.

Managers and Directors

Sector and Competitors

Source: marketscreener.com

05/26/2023 | 10:22am EDT

© MT Newswires 2023

All news about THE BEAUTY HEALTH COMPANY

Analyst Recommendations on THE BEAUTY HEALTH COMPANY

Financials (USD)

Sales 2023 465 M
Net income 2023 14,5 M
Net Debt 2023 173 M
P/E ratio 2023 105x
Yield 2023
Capitalization 1 283 M 1 283 M
EV / Sales 2023 3,13x
EV / Sales 2024 2,53x
Nbr of Employees 1 034
Free-Float 98,8%

Chart THE BEAUTY HEALTH COMPANY

Duration :


Period :

The Beauty Health Company Technical Analysis Chart | MarketScreener

Technical analysis trends THE BEAUTY HEALTH COMPANY

Short Term Mid-Term Long Term
Trends Bearish Neutral Neutral

Income Statement Evolution

Sell

Buy

Mean consensus BUY
Number of Analysts 11
Last Close Price 9,67 $
Average target price 18,11 $
Spread / Average Target 87,3%

EPS Revisions

Managers and Directors

Sector and Competitors

Source: marketscreener.com

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai

Leave a Comment